Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.
about
Mitochondrial 2,4-dienoyl-CoA reductase deficiency in mice results in severe hypoglycemia with stress intolerance and unimpaired ketogenesisAMP-activated protein kinase, stress responses and cardiovascular diseasesTranscriptional regulation of hepatic lipogenesisExposure to bisphenol-A during pregnancy partially mimics the effects of a high-fat diet altering glucose homeostasis and gene expression in adult male miceThe orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPKChicoric acid is an antioxidant molecule that stimulates AMP kinase pathway in L6 myotubes and extends lifespan in Caenorhabditis elegansAMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons.Gene expression profiling of liver from dairy cows treated intra-mammary with lipopolysaccharide.Transgenic muscle-specific Nor-1 expression regulates multiple pathways that effect adiposity, metabolism, and enduranceDeficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance.Anti-obesity activity, acute toxicity, and chemical constituents of aqueous and ethanol Viola mandshurica extracts.Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out miceMorinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction.Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominidsMetformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle.Interleukin-6 deficiency causes tissue-specific changes in signaling pathways in response to high-fat diet and physical activity.A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo.Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liverSodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.Effects of a multi-herbal extract on type 2 diabetesCentral endocannabinoid signaling regulates hepatic glucose production and systemic lipolysisAcetic acid activates the AMP-activated protein kinase signaling pathway to regulate lipid metabolism in bovine hepatocytesHematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice.Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcriptionAliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet.A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells.Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissueEffect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL/6 mice.AMPK inhibition in health and disease.Effects of Tithonia diversifolia (Hemsl.) A. Gray extract on adipocyte differentiation of human mesenchymal stem cellsVoluntary physical activity prevents insulin resistance in a tissue specific mannerInflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice.Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells.Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake.Adiponectin receptor signalling in the brainDeletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouseMechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.
P2860
Q21563343-DDF33030-FAB8-42ED-965D-41449E45E705Q24610297-1B3F7C5D-1FC6-4117-B9FB-147F2A69D4B8Q26778594-3195996D-FD61-4561-ADEA-F44698744C00Q27322754-5A79B35A-22BB-4447-BEF8-E47065322A3BQ27682265-9614DE93-99C9-4D49-8291-22810DE59473Q28535013-4DA891EA-51CB-464D-B0C4-5B55A64CFC07Q30479831-7C574612-C4C2-46E7-BCD1-6503A8BE64BFQ33371819-B5A24728-929A-4A57-A72E-4E81E8D5A0BDQ33668991-35CCCC3F-A883-4E63-AC88-73C5D95A995DQ33750723-F815D0B3-CDAD-4739-A226-4EEBD5416AD3Q33771865-F14B6E2A-7003-41F2-920A-B437FD88A9D2Q33800037-FDBE21ED-928C-4ABE-8A85-AEFC6745F19FQ33851783-502C5C4A-D2E2-4F92-A028-F666E4186DA5Q33913203-15439E68-E35F-4CC9-B993-7CD2925AC647Q33968008-F9FE0564-A42E-40D0-A38D-6F8838BD2B63Q34020241-F12E0767-7BB9-4391-8299-8334ADA68950Q34297417-067277F0-C3C1-4DA8-BD1F-C9A39916CEF8Q34355140-510BE571-88FB-4F49-9D0F-D02301B07B8CQ34477493-DB6277F7-8714-46DC-AEF4-BEA0FBF24106Q34592438-FB03E183-6695-418A-A719-48386E6A47E0Q34603754-27596A7B-7275-4FF0-9F9B-B6815AE28FA6Q34675761-D866AA6E-EB47-451D-9073-0C703F3AB22EQ34693060-81A17B1E-72FF-4715-B959-965AD3A2F65EQ34718604-9C79A3F8-03BE-44BD-BD93-D9B27FD62E47Q34826374-6B1C1A49-A0AE-40F7-9900-297364E836C4Q35008532-672289D9-652D-4222-A379-23F2CF0CADB6Q35022533-CC60CADD-D6D5-45E8-971D-5D3FE2EE4223Q35035662-2A91B5F9-7059-4C97-9C89-E2F8C2682637Q35038522-64E9A0E1-2C60-46E2-885B-629438992960Q35041508-04095B00-44A3-47C4-8F33-53F3CC6AA7A2Q35064804-AAD81BA7-902C-44B2-83FE-ED960E9279A0Q35094436-9D9A1342-2CEB-4121-AB1D-1158E6215BE7Q35301598-13D3CAAD-F989-4D12-B26D-23F76FF02C93Q35363510-6BD087B7-C1FE-4DFF-BC8B-CC27A9CAA703Q35402168-AEB0CBBD-AC8F-4FCF-AB3A-E2BEB6D217CBQ35573397-05A56F12-3185-4380-8E87-F8F52254A024Q35665721-5E48F690-11EF-4E6E-86F7-CA8C5B23C3EFQ35708104-8C3E1CCF-D0E9-45C3-AB97-C7C6385B1478Q35744039-5D63DD74-49E6-4E4F-96AF-1300948F7307Q35757790-33B5BD76-53A0-44BA-8750-221319B71B49
P2860
Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Activation of AMP-activated pr ...... f metabolic hepatic disorders.
@ast
Activation of AMP-activated pr ...... f metabolic hepatic disorders.
@en
type
label
Activation of AMP-activated pr ...... f metabolic hepatic disorders.
@ast
Activation of AMP-activated pr ...... f metabolic hepatic disorders.
@en
prefLabel
Activation of AMP-activated pr ...... f metabolic hepatic disorders.
@ast
Activation of AMP-activated pr ...... f metabolic hepatic disorders.
@en
P2093
P2860
P50
P1476
Activation of AMP-activated pr ...... f metabolic hepatic disorders.
@en
P2093
Fabrizio Andreelli
Luc Bertrand
Sandrine Horman
P2860
P356
10.1113/JPHYSIOL.2006.108506
P407
P577
2006-04-27T00:00:00Z